Codes / ICD10CM / H15.113

H15.113 Episcleritis periodica fugax, bilateral

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Episcleritis periodica fugax, bilateral

Summary

Episcleritis periodica fugax, bilateral is a specific form of episcleritis characterized by recurrent, transient episodes of inflammation in the episclera of both eyes. These episodes are typically brief and self-resolving, though they may cause mild eye redness and discomfort. The condition is distinguished by its episodic nature and tendency to resolve spontaneously, with both eyes being the affected sites.

Causes

The exact cause of episcleritis periodica fugax is often idiopathic, meaning it may occur without a clear underlying trigger. It can be associated with systemic conditions such as autoimmune disorders, infections, or environmental factors like dryness or irritation. The transient nature of the episodes suggests a reactive or self-limiting inflammatory process.

Risk Factors

  • Autoimmune disorders
  • History of episcleritis or related eye inflammations
  • Exposure to environmental irritants or dry conditions

Symptoms

  • Recurrent episodes of bilateral eye redness
  • Mild eye pain or discomfort in both eyes
  • Transient inflammation lasting hours to days
  • Possible sensitivity to light in both eyes

Diagnosis

Diagnosis involves a physical examination of both eyes by an ophthalmologist, often using a slit-lamp to assess inflammation. Patient history is reviewed to identify patterns of recurrence and associated systemic conditions. No specific diagnostic tests are typically required, as the condition is diagnosed clinically based on presentation and history.

Treatment Options

Treatment is often supportive, focusing on symptom relief. Mild cases may not require intervention, as episodes are self-resolving. For discomfort, lubricating eye drops or over-the-counter anti-inflammatory drops may be used. Severe or persistent cases may involve prescription topical steroids or oral anti-inflammatory medications. Underlying systemic conditions, if present, should be addressed.

Prognosis and Follow-Up

The prognosis is generally favorable, as episodes are transient and self-limiting. Most patients experience no long-term vision impairment. Follow-up may be recommended to monitor for recurrence or progression, especially if systemic conditions are suspected. Regular eye examinations can help ensure no complications arise.

Complications

Complications are rare but may include corneal involvement, which can lead to vision changes, or progression to more severe forms of episcleritis or scleritis. Chronic inflammation could potentially affect eye structure, though this is uncommon in episcleritis periodica fugax.

Lifestyle & Prevention

Avoiding known irritants, such as dry environments or allergens, may help reduce episodes. Using lubricating eye drops regularly can alleviate dryness. Managing underlying conditions, like autoimmune disorders, through appropriate treatment may also minimize recurrence. Protective eyewear in dusty or windy conditions is advisable.

When to Seek Professional Help

Seek care if episodes become more frequent, severe, or prolonged, or if vision changes occur. Persistent pain, significant redness, or sensitivity to light warrant evaluation. If systemic symptoms (e.g., fever, joint pain) accompany eye inflammation, prompt medical attention is recommended to rule out underlying conditions.

Tips for Medical Coders

Document the bilateral nature of the condition clearly in the medical record, as this is a key differentiator for code H15.113. Ensure the episodic and transient nature of the inflammation is noted, as this distinguishes it from chronic or progressive forms. Include any associated systemic conditions or triggers if identified, as these may impact coding specificity. Verify that the diagnosis aligns with clinical findings and patient history to support accurate code assignment.

Book a walkthrough

H15.113 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.